TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 51 filers reported holding TCR2 THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 20.14 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,000 | -36.4% | 2,381 | 0.0% | 0.00% | – |
| Q4 2021 | $11,000 | -84.7% | 2,381 | -71.8% | 0.00% | – |
| Q3 2021 | $72,000 | +24.1% | 8,435 | +137.5% | 0.00% | – |
| Q2 2021 | $58,000 | -27.5% | 3,552 | -1.2% | 0.00% | – |
| Q1 2021 | $80,000 | -23.1% | 3,594 | +6.2% | 0.00% | – |
| Q4 2020 | $104,000 | +131.1% | 3,385 | +52.9% | 0.00% | – |
| Q3 2020 | $45,000 | +40.6% | 2,214 | +4.9% | 0.00% | – |
| Q2 2020 | $32,000 | +220.0% | 2,110 | +34.2% | 0.00% | – |
| Q1 2020 | $10,000 | -65.5% | 1,572 | -21.3% | 0.00% | – |
| Q4 2019 | $29,000 | 0.0% | 1,998 | +2.1% | 0.00% | – |
| Q3 2019 | $29,000 | +262.5% | 1,956 | +258.9% | 0.00% | – |
| Q2 2019 | $8,000 | – | 545 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 3,370,982 | $68,498,000 | 16.50% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $82,314,000 | 15.35% |
| Consonance Capital Management LP | 1,509,819 | $30,680,000 | 3.74% |
| Soleus Capital Management, L.P. | 282,041 | $5,731,000 | 3.04% |
| Redmile Group, LLC | 2,793,288 | $56,760,000 | 1.04% |
| PFM Health Sciences, LP | 775,794 | $15,764,000 | 0.73% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,200,000 | $24,384,000 | 0.59% |
| Cormorant Asset Management, LP | 600,000 | $12,192,000 | 0.47% |
| Sofinnova Investments, Inc. | 173,028 | $3,516,000 | 0.26% |
| Artal Group S.A. | 500,000 | $10,160,000 | 0.25% |